Copyright 2001 American Medical Association. All Rights Reserved.
Applicable FARS/DFARS Restrictions Apply to Government Use.2001
I read with great interest the clinicopathologic report by Irvine et
al.1 This report clearly and rightly favors
the more conservative approach of local transcleral resection of peripheral
retinal vasoproliferative masses, which cannot be positively differentiated
from malignant melanoma of the choroid. This not only saves the patient an
unnecessary enucleation but also spares the surgeon from the embarrassment
of removing an eye that is noncancerous. I believe that in cases with no evidence
of preoperative choroidal involvement, it is better not to implant the ruthenium
106 plaque until the results of the histopathological examination are available.
This will save the patient from the second surgical procedure of removing
the plaque, which may be unnecessary in the first place. If, however, the
histopathological report confirms a malignant melanoma, a ruthenium 106 plaque
should be applied.
Tripathi A. Retinal Vasoproliferative Tumors: A Conservative Approach. Arch Ophthalmol. 2001;119(1):145. doi: